These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 28425869)
1. Development of a Chitosan-based Nanoparticle Formulation for Ophthalmic Delivery of Honokiol. Deng F; Hu W; Chen H; Tang Y; Zhang L Curr Drug Deliv; 2018; 15(4):594-600. PubMed ID: 28425869 [TBL] [Abstract][Full Text] [Related]
2. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery. Mahmoud AA; El-Feky GS; Kamel R; Awad GE Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097 [TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery. Zhang P; Liu X; Hu W; Bai Y; Zhang L Carbohydr Polym; 2016 Sep; 149():224-30. PubMed ID: 27261746 [TBL] [Abstract][Full Text] [Related]
4. Honokiol nanoparticles based on epigallocatechin gallate functionalized chitin to enhance therapeutic effects against liver cancer. Tang P; Sun Q; Yang H; Tang B; Pu H; Li H Int J Pharm; 2018 Jul; 545(1-2):74-83. PubMed ID: 29715531 [TBL] [Abstract][Full Text] [Related]
5. Honokiol nanosuspensions: preparation, increased oral bioavailability and dramatically enhanced biodistribution in the cardio-cerebro-vascular system. Han M; Yu X; Guo Y; Wang Y; Kuang H; Wang X Colloids Surf B Biointerfaces; 2014 Apr; 116():114-20. PubMed ID: 24448177 [TBL] [Abstract][Full Text] [Related]
6. Investigation of inclusion complex of honokiol with sulfobutyl ether-β-cyclodextrin. Xu C; Tang Y; Hu W; Tian R; Jia Y; Deng P; Zhang L Carbohydr Polym; 2014 Nov; 113():9-15. PubMed ID: 25256452 [TBL] [Abstract][Full Text] [Related]
7. Sulfobutylether-β-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel. Wu J; Shen Q; Fang L Drug Dev Ind Pharm; 2013 Jul; 39(7):1010-9. PubMed ID: 22681515 [TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome. Wang X; Deng L; Cai L; Zhang X; Zheng H; Deng C; Duan X; Zhao X; Wei Y; Chen L J Pharm Sci; 2011 Aug; 100(8):3357-3364. PubMed ID: 21387317 [TBL] [Abstract][Full Text] [Related]
9. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone. Kalam MA Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165 [TBL] [Abstract][Full Text] [Related]
10. The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes. Ye YJ; Wang Y; Lou KY; Chen YZ; Chen R; Gao F Int J Nanomedicine; 2015; 10():4309-19. PubMed ID: 26170666 [TBL] [Abstract][Full Text] [Related]
11. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery. Rukmangathen R; Yallamalli IM; Yalavarthi PR Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571 [No Abstract] [Full Text] [Related]
12. Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery. Li X; Guo Q; Zheng X; Kong X; Shi S; Chen L; Zhao X; Wei Y; Qian Z Drug Deliv; 2009 Apr; 16(3):160-6. PubMed ID: 19514976 [TBL] [Abstract][Full Text] [Related]
13. Mucoadhesive chitosan-dextran sulfate nanoparticles for sustained drug delivery to the ocular surface. Chaiyasan W; Srinivas SP; Tiyaboonchai W J Ocul Pharmacol Ther; 2013 Mar; 29(2):200-7. PubMed ID: 23356788 [TBL] [Abstract][Full Text] [Related]
14. Targeting Inflammatory Lesions Facilitated by Galactosylation Modified Delivery System Eudragit/Gal-PLGA@Honokiol for the treatment of Ulcerative Colitis. Wang A; Liu Y; Xiong W; Li W; Li J; Yang Z; Zou Z; Luo Y; Chen Z; Li H; Vong CT; Zou L J Pharm Sci; 2024 Sep; 113(9):2744-2755. PubMed ID: 38901529 [TBL] [Abstract][Full Text] [Related]
15. Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eye. Nagarwal RC; Kumar R; Pandit JK Eur J Pharm Sci; 2012 Nov; 47(4):678-85. PubMed ID: 22922098 [TBL] [Abstract][Full Text] [Related]
16. Chitosan/sulfobutylether-β-cyclodextrin based nanoparticles coated with thiolated hyaluronic acid for indomethacin ophthalmic delivery. Ricci F; Racaniello GF; Lopedota A; Laquintana V; Arduino I; Lopalco A; Cutrignelli A; Franco M; Sigurdsson HH; Denora N Int J Pharm; 2022 Jun; 622():121905. PubMed ID: 35697201 [TBL] [Abstract][Full Text] [Related]
17. Chitosan nanoparticles of 5-fluorouracil for ophthalmic delivery: characterization, in-vitro and in-vivo study. Nagarwal RC; Singh PN; Kant S; Maiti P; Pandit JK Chem Pharm Bull (Tokyo); 2011; 59(2):272-8. PubMed ID: 21297311 [TBL] [Abstract][Full Text] [Related]
18. Sulfobutylether-β-cyclodextrin/chitosan nano- and microparticles and their physicochemical characteristics. Fülöp Z; Saokham P; Loftsson T Int J Pharm; 2014 Sep; 472(1-2):282-7. PubMed ID: 24971695 [TBL] [Abstract][Full Text] [Related]
19. Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma. Li J; Tian S; Tao Q; Zhao Y; Gui R; Yang F; Zang L; Chen Y; Ping Q; Hou D Int J Nanomedicine; 2018; 13():3975-3987. PubMed ID: 30022821 [TBL] [Abstract][Full Text] [Related]
20. A novel composite drug delivery system: honokiol nanoparticles in thermosensitive hydrogel based on chitosan. Li X; Zheng X; Wei X; Guo G; Gou M; Gong C; Wang X; Dai M; Chen L; Wei Y; Qian Z J Nanosci Nanotechnol; 2009 Aug; 9(8):4586-92. PubMed ID: 19928122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]